Sight Sciences, Inc. SGHT 深 沪
已收盘 05-22 16:00:00 美东时间
5.03
-0.110
-2.14%
华盛通- 最 高5.23
- 今 开5.19
- 成交量 15.06万股
- 最 低 4.97
- 昨 收 5.14
- 总市值 2.74亿
- 52周最高 9.2362
- 市盈率 静 --
- 换手率 0.28%
- 52周最低 3.11
- 委 比 11.05%
- 总股本 5440.99万
- 历史最高 42.57
- 量 比 0.81
- 振 幅 5.06%
- 历史最低 1.04
- 每 手 1
- 风险率 1.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sight Sciences shares are trading higher. The company reported Q1 financial results and raised its FY26 sales guidance with its midpoint above estimates.
Sight Sciences shares are trading higher. The company reported Q1 financial res...
05-07 22:54
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
U.S. District Court Preserves Jury's Willful Infringement Verdict In Sight Sciences Case Vs Alcon
Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve
03-30 19:09
美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
Sight Sciences shares are trading lower after the company reported worse-than-expected Q4 sales results.
Sight Sciences shares are trading lower after the company reported worse-than-e...
03-06 00:01
Sight Sciences Q4 Earnings Assessment
The earnings results for Sight Sciences (NASDAQ:SGHT) for Q4 were made public o...
03-05 05:48
Earnings Scheduled For March 4, 2026
Companies Reporting Before The Bell • Dingdong (Cayman) (NYSE:DDL) is estimated...
03-04 19:11
Uncovering Potential: Sight Sciences's Earnings Preview
Sight Sciences (NASDAQ:SGHT) is gearing up to announce its quarterly earnings o...
03-04 04:01
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
Stifel Maintains Buy on Sight Sciences, Raises Price Target to $8
Stifel analyst Thomas Stephan maintains Sight Sciences (NASDAQ:SGHT) with a Buy and raises the price target from $6 to $8.
03-03 01:44
